Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed.

1. Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus?Frontiers in immunology · 2018
   Trial
2. The therapeutic potential of transposable element activity modulation.EMBO molecular medicine · 2026
   Review
3. Fingolimod increases cellular resistance to HIV-1 infection and limits viral reservoir size in peripheral CD4+ T-cells.PLoS pathogens · 2026
   Article
4. Nucleoside-Analog Reverse-Transcriptase Inhibitors (NRTIs) Against Multiple Sclerosis: Comprehensive Review on a Possible Novel Therapeutic Approach.Neurology international · 2026
   Review
5. The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis.Brain : a journal of neurology · 2025
   Review
6. Concomitant diagnosis of multiple sclerosis and human immunodeficiency virus (HIV) infection: case report and the review of literature.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
   Review
7. Interaction of the viral infectious agents in the development and exacerbation of the multiple sclerosis.Le infezioni in medicina · 2023
   Review
8. Modulation of human endogenous retroviruses and cytokines expression in peripheral blood mononuclear cells from autistic children and their parents.Retrovirology · 2022
   Article
9. HIV infection and multiple sclerosis: a case with unexpected "no evidence of disease activity" status.The Journal of international medical research · 2021
   Article
10. Epstein-Barr Virus and Neurological Diseases.Frontiers in molecular biosciences · 2021
    Review
11. Acquisition of human immunodeficiency virus infection in a patient with multiple sclerosis: could these conditions positively influence each other's course?Journal of neurovirology · 2020
    Article
12. Human immunodeficiency virus and multiple sclerosis: a review of the literature.Neurological research and practice · 2019
    Review
13. Could antiretrovirals be treating EBV in MS? A case report.Multiple sclerosis and related disorders · 2018
    Article
14. Treatment of Theiler's virus-induced demyelinating disease with teriflunomide.Journal of neurovirology · 2017
    Article
15. Blinded by Zika? A missed HIV diagnosis that resulted in optic neuropathy and blindness: a case report.BMC research notes · 2017
    Article
16. Cooccurrences of Putative Endogenous Retrovirus-Associated Diseases.BioMed research international · 2017
    Review
17. Multiple sclerosis and HIV-1 infection: case report of a HIV controller.Journal of neurovirology · 2015
    Article
18. Multiple Sclerosis and Subsequent Human Immunodeficiency Virus Infection: A Case with the Rare Comorbidity, Focus on Novel Treatment Issues and Review of the Literature.In vivo (Athens, Greece)
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as